bf/NASDAQ:REGN_icon.jpeg

NASDAQ:REGN

Regeneron Pharmaceuticals, Inc.

  • Stock

590.00

−1.46%

26.90

USD last updated 26/07 01:59:53

Last Close

563.10

25/07 20:01

Market Cap

116.07B

Beta: 0.23

Volume Today

1.11M

Avg: 576.83K

PE Ratio

25.31

PFCF: 33.11

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein oc...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    5101520252017-08-032019-08-062021-08-052023-08-032025-02-07

    Revenue (Estimate*)

    1B2B3B4B5B2017-08-032019-08-062021-08-052023-08-032025-02-07

    *Estimate based on analyst consensus